The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome.
Saved in:
| Title: | The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome. |
|---|---|
| Authors: | Clina JG; Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA., Helsel BC; Department of Neurology University of Kansas Medical Center Kansas City Kansas USA., Hartley SL; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA.; Department of Human Development and Family Studies University of Wisconsin-Madison Madison Wisconsin USA., White DA; Ward Family Heart Center Children's Mercy Hospital Kansas City Missouri USA., Fleming-Batayneh VL; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA.; Department of Human Development and Family Studies University of Wisconsin-Madison Madison Wisconsin USA., Handen B; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA., Christian B; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA.; Department of Psychiatry University of Wisconsin-Madison Madison Wisconsin USA., Head E; Department of Pathology & Laboratory Medicine University of California, Irvine School of Medicine Irvine California USA., Mapstone M; Department of Psychiatry and Human Behavior University of California, Irvine School of Medicine Irvine California USA., Hom CL; Department of Psychiatry and Human Behavior University of California, Irvine School of Medicine Irvine California USA., Ances B; Department of Neurology Washington University Saint Louis St. Louis Missouri USA., Burns J; Department of Neurology University of Kansas Medical Center Kansas City Kansas USA., Rosas HD; Department of Neurology Harvard Medical School Massachusetts General Hospital Boston Massachusetts USA., Lai F; Department of Neurology Harvard Medical School Massachusetts General Hospital Boston Massachusetts USA., McHale SK; Department of Psychology New York State Institute for Basic Research in Developmental Disabilities New York New York USA., Lee JH; Department of Neurology Columbia University Irving Medical Center New York New York USA.; Department of Epidemiology Columbia University Irving Medical Center New York New York USA., Schmitt FA; Department of Neurology University of Kentucky Lexington Kentucky USA., Harp J; Department of Neurology University of Kentucky Lexington Kentucky USA., Lott IT; Department of Pediatrics University of California Irvine School of Medicine Irvine California USA., Zaman S; Cambridge Intellectual and Developmental Disabilities Research Group University of Cambridge Douglas House Cambridge UK., Ptomey LT; Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA. |
| Corporate Authors: | Alzheimer Biomarker Consortium–Down Syndrome (ABC‐DS) Investigators |
| Source: | Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2026 Jan 18; Vol. 18 (1), pp. e70257. Date of Electronic Publication: 2026 Jan 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2352-8729 |
|---|---|
| DOI: | 10.1002/dad2.70257 |
